The Lind Partners: Media sponsor of "Stars in 2013" Industrial Forum
The New York-based asset management firm 'The
Lind Partners' is Media Sponsor of Proactive Investors' "Stars in
2013" Investor Forum to be held in Sydney on Tuesday 4th June 2013.
Attendance is free but registrations are essential as seats are limited.
The Lind is a New York-based asset management firm that manages a family of
institutional investment funds focused on small- and mid-cap publicly traded
companies with an emphasis on Australia, Canada and the United Kingdom.
Jeff Easton is the founder and managing director of The
Lind Partners, and has spent over 15 years in the funds management
business, and in 2009 co-founded SpringTree Global Investors, a New York-based
institutional investment firm.
PRESENTING COMPANIES
TZ
Limited (ASX:TZL)
Chairman Mark Bouris' TZ
Limited (ASX: TZL) leverages its Intellectual Property and
technology and over 180 patent applications in process, the distributed
intelligence of TZ SMArt Devices™ and SMArt Systems™ provide solutions
including the Automated Delivery Asset Manager (ADAM) locker system for online
shoppers.
Novogen (ASX:NRT)
Novogen (ASX: NRT) has set itself the lofty goal of conquering cancer by developing the
CS-6 comprehensive cancer therapy. A bold endeavor that Novogen is passionate about, committed to, and focused on. See why Novogen believes it can succeed where so many others have not fared well.
Cellmid (ASX:CDY)
Cellmid (ASX: CDY) is focused on developing innovative new therapies
and diagnostic tests for heart attack, inflammatory diseases and cancer. Cellmid set up a dedicated subsidiary, Advangen International Pty Ltd, for the development
of midkine for hair growth. In May, Cellmid made a transformative acquisition of Advangen Inc., Japan, the company that
owns the FGF-5 inhibitor hair growth technology.
E&A
Limited (ASX:EAL)
E&A
Limited (ASX: EAL) is a dividend-paying company based in South Australia
and operates nine wholly owned operating businesses providing services across
the financial services, mining, defence, water, wind power and heavy industry
sectors.
Bluechiip Limited (ASX: BCT)
Bluechiip Limited (ASX: BCT) is global technology company that provides a
unique chain‐of‐custody tracking and monitoring tool which is initially focused
on the life science market. Biobanking is the company's first market, where
there is a broad and rapidly growing demand.
Related news
- Yellow Diamonds - A Gap in the Diamond market
- Coffee with Samso: Episode 1, Australian Tungsten Projects and How the Chinese Market View The Tungsten sector
- Chasing for Kryptonite, the unknown other Lithium source
- What is In-Situ Recovery? Mining in a National Park with no environmental footprint
- Buds & Duds: Cannabis stocks drop but Weekend Unlimited shares jump on CBD hemp seed news
- Hemispherx treats first patient with cancer drug Ampligen in Phase 2 clinical trials
- THC Global granted cannabis Manufacture Licence, shares surge 20%
.jpg)